See also this year's filing and all EDGAR filings for this company.
PDF Report 0001367920_2016_Concert_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001367920, Concert Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 144,108,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 2,346,000 |
| 3 | remainder_Assets | 478,000 |
| 4 | LiabilitiesCurrent | 6,627,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 9,670,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 13,056,000 |
| 9 | ResearchAndDevelopmentExpense | 28,885,000 |
| 10 | remainder_Expenses | 429,000 |
| 11 | remainder_Revenues | 66,729,000 |
| 12 | remainder_NetIncome | -185,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 146,932,000 |
| 1 | Liabilities | 16,297,000 |
| 2 | Expenses | 42,370,000 |
| 3 | Revenues | 66,729,000 |
| 4 | StockholdersEquity | 130,635,000 |
| 5 | NetIncome | 24,174,000 |
| 6 | ComprehensiveNetIncome | 24,174,000 |
| 7 | BaseVar | 136,256,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.79 |
| 9 | EconomicCapitalRatio | 4.23 |